– FRANCE, Paris – FeetMe, a medical device company that produces smart medical wearables and digital health services to improve mobility, today announced it has raised € 9.4 million in Series A funding. The investment round was led by LBO France, with additional investment from existing investors Kurma Diagnostics, the fund Paris Saclay seed fund, Idinvest Partners, Seventure and SOSV.
Alexis Mathieu, founder and CEO at FeetMe said: “Our platform has demonstrated it can generate unique insights and real-world evidence to accelerate clinical research at scale, and our FeetMe Evaluation solution is setting a new standard for long-term continuous mobility assessment of patients with gait disorders. This Series A round will help FeetMe to accelerate commercial activities.”
Philippe Chambon, Venture Partner at LBO France said: “With its disruptive yet technically validated technology, FeetMe establishes itself as the global leader in long-term continuous mobility assessment, with the potential to improve diagnosis for the millions of patients each year who present with known and unknown walking difficulties. I believe that FeetMe, with its vast technology capabilities, has the ability to create the world’s largest and highest quality gait pattern data set to create a variety of new digital biomarkers across disease areas.”
The fundraising will enable the acceleration of FeetMe commercial activities in clinical trials for the pharmaceutical industry and healthcare services for hospitals and rehabilitation facilities worldwide.
The innovative technology from FeetMe allows gait and posture analysis in real-time and real-life conditions. The technology combines pressure sensors, motion sensors and learning algorithms to analyze patients’ functional capacity, as well as empower rehabilitation among sufferers of gait disorders. FeetMe proposes the world’s first and most advanced technology platform for real-world disease diagnostics, monitoring and rehabilitation based on movement data.
100 million people worldwide suffer from gait disorders. Gait disorders are often a forerunner and indicator of evolutive diseases and health status: multiple sclerosis, Parkinson disease, fragility among elderly, peripheral neuropathies and diabetic foot problems.
FeetMe is a certified medical device company developing smart medical wearables to improve mobility based on connected insoles.
For more information: https://feetme.fr
About LBO France / Innovation Capital
As a key player in private equity with €4bn of capital under management, LBO France is an independent company that has been supporting French and Italian companies in their growth for more than 30 years. Its investment strategy is built on 4 distinct segments managed by dedicated teams: Mid Cap Buyout through the White Knight funds and Small-Cap Buyout through the Hexagone/Small Caps Opportunities funds; Venture Capital through the SISA/Digital Health funds; Real Estate through the White Stone and Lapillus funds; Debt. LBO France is 100% owned by its management and employs nearly 60 professionals.
- Disclaimer - News, data and statement included in this release are intended exclusively for general information purposes. Talent4Boards accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the adequacy or accuracy of the information. No data or statement in this release should be considered for decisions about securities referred. Product and brand names used in this release maybe trademarks or registered trademarks of their respective owners.
Comments are closed.